2015-12-23

[#DIV28SUPER] National Institute on Drug Abuse Request for Applications (RFAs) for HIV/AIDS research

Table of Contents:

 

I.      NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

(NOT-OD-15-137)

National Institutes of Health

Office of AIDS Research

2.    Exploring Epigenomic or Non-Coding RNA Regulation in HIV/AIDS and Substance Abuse (R01)
(RFA-DA-16-012)
National Institute on Drug Abuse
Application Receipt Date(s): March 02, 2016

3.    Systems Biology Approaches in HIV/AIDS and Substance Use (R01)
(RFA-DA-16-013)
National Institute on Drug Abuse
Application Receipt Date(s): April 04, 2016

4.    Effects of Drugs of Abuse on Latent HIV Reservoirs in the CNS (R01)
(RFA-DA-16-014)
National Institute on Drug Abuse
Application Receipt Date(s): March 3, 2016 by 5:00 PM local time of applicant organization

5.    Seek, Test, Treat and Retain For Youth and Young Adults Living with or at High Risk for Acquiring HIV (R01)

(RFA-DA-16-010)

National Institute on Drug Abuse

Application Receipt Date(s): March 2, 2016, by 5:00 PM local time of applicant organization.

 

1.    NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

(NOT-OD-15-137)

National Institutes of Health

Office of AIDS Research

The purpose of this Notice is to inform the scientific community of the overarching HIV/AIDS research priorities and the guidelines NIH will use for determining AIDS funding beginning in fiscal year 2016 for the next three to five years. (Please read entire notice for details)

 

2.    Exploring Epigenomic or Non-Coding RNA Regulation in HIV/AIDS and Substance Abuse (R01)
(RFA-DA-16-012)
National Institute on Drug Abuse
Application Receipt Date(s): March 02, 2016

The goal of this Funding Opportunity Announcement (FOA) is to stimulate innovative hypothesis-driven research to enhance our understanding of the role of epigenomic or non-coding RNA regulatory mechanisms in HIV/AIDS infection or disease trajectory in combination with substance use or abuse.  We are particularly interested in understanding regulatory mechanisms that influence selection and regulation of HIV sites of integration in the host genome.  A deeper understanding of these mechanisms could lead to novel approaches for monitoring latent HIV in cellular reservoirs, especially in the central nervous system.  Ultimately, research in this area could enable the identification of molecular targets that could be manipulated either to eliminate or permanently repress HIV in cellular reservoirs. (Please read entire Funding Opportunity Announcement for details

 

3.    Systems Biology Approaches in HIV/AIDS and Substance Use (R01)
(RFA-DA-16-013)
National Institute on Drug Abuse
Application Receipt Date(s): April 04, 2016

The purpose of this Funding Opportunity Announcement (FOA) is to support systems biology research projects that address critical questions in HIV/AIDS research in the context of drugs of abuse.  Substance use and abuse present unique challenges for HIV prevention, treatment, disease progression, medical consequences, potential cure, and responses to vaccines or therapeutics.  Understanding the complex biological intersection of HIV/AIDS and substance use and abuse is the central theme of this FOA.  (Please read entire Funding Opportunity Announcement for details)

 

 

4.    Effects of Drugs of Abuse on Latent HIV Reservoirs in the CNS (R01)
(RFA-DA-16-014)
National Institute on Drug Abuse
Application Receipt Date(s): March 3, 2016 by 5:00 PM local time of applicant

The purpose of this FOA is to promote research to investigate the underlying molecular mechanisms by which HIV latency is initiated, established, and maintained in the CNS and to determine how drugs of abuse modulate HIV latency and the size and persistence of CNS HIV reservoirs. The ultimate goal is to obtain information for developing new or improved therapies for HIV treatment in drug-abusing populations. (Please read entire Funding Opportunity Announcement for details)

 

 

5.    Seek, Test, Treat and Retain For Youth and Young Adults Living with or at High Risk for Acquiring HIV (R01)

(RFA-DA-16-010)

National Institute on Drug Abuse

Application Receipt Date(s): March 2, 2016, by 5:00 PM local time of applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to examine seek, test, treat and retain approaches among youth and young adults (ages 13-25) who are at high risk for HIV acquisition or have already acquired HIV. Applications should incorporate substance use into study aims; objectives should address substance use prevention, screening, and/or treatment in ways that facilitate use of HIV prevention and treatment services. Youth are the target of this RFA because they demonstrate lower levels of screening and engagement across the HIV continuum of care and HIV+ youth are less likely to achieve viral suppression than those at older ages. These disparities are evident in US and foreign populations. The developmental, structural, and systemic factors related to serving youth need to be clearly incorporated into study aims, rather than simple incremental refocusing of existing interventions to younger people. Both domestic and international projects will be supported. (Please read entire Funding Opportunity Announcement for details)

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

 

 

1 comment:

hoffmanloretta1 said...

A report by the Drug Enforcement Administration in 2007 found that the abuse of a particular painkiller, Fentanyl ate up the lives of more than 1,000 people in that one year alone. It was found to be fifty times more powerful than heroin. 3 About 2.2 million teenagers have admitted to have abused over the counter drugs like cough syrups and pain killers.
http://www.reatarehab.com/drug-profile-prescription-drugs/

Post a Comment